Blue Shield of California announced it will drop the complicated system that Americans use to pay for drugs, and create something that seeks to be better, with partners including Amazon.com (AMZN) and entrepreneur Mark Cuban, The Wall Street Journal’s Anna Wilde Mathews reports. Blue Shield of California said it is dropping CVS Health’s (CVS) Caremark, the pharmacy-benefit manager it currently uses, which negotiates drug prices and wraps in other services such as a mail-order pharmacy. Instead, Blue Shield will work with a selection of companies that each perform a designated function. Amazon will offer at-home drug delivery. Cuban said Mark Cuban Cost Plus Drug Company will provide access to low-cost medications, including through retail pharmacies. Another company, Abarca, will process drug claims.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CVS:
- Cigna (NYSE:CI) and Others Face Aftermath of Blue Shield’s Move
- CVS Health’s (NYSE: CVS) Caremark Dropped by Blue Shield of California
- 5 Healthcare Stocks to Buy Now, According to Analysts – August 2023
- Biomerica announces CVS has begun rollout of its EZ Detect colorectal test
- CVS Health price target lowered to $98 from $103 at Truist
